As fundamentals-focused long-term investors, Fools never base an investment decision on the daily gyrations of the market. But the market's daily price movements can be useful when looking for new stock ideas for further research, or to keep tabs on watch-list stocks.

Below you'll find today's biggest movers among our five-star stocks -- the highest rating awarded by our CAPS community of more than 125,000 investors. Have a look, and then visit us on CAPS to dig in further on each of them.


Up Today


Sector Past 30 Days

Fools Saying Outperform


China Infrastructure Investment



Transportation Infrastructure


15 of 15


Tiens Biotech Group



Personal Products


244 of 257


Taro Pharmaceutical Industries





26 of 31


Other Five-Star Transportation Infrastructure
Grupo Aeroportuario del Pacific (NYSE:PAC) down 2.56%
Grupo Aeroportuario del Sureste (NYSE:ASR) down 4.30%
Other Five-Star Personal Products
Nutraceutical Int'l (NASDAQ:NUTR) no change
American Oriental Bioengineering down 1.65%
Other Five-Star Pharmaceuticals
Aryx Therapeutics (NASDAQ:ARYX) up 15.21%
Acusphere (NASDAQ:ACUS) up 4.29%

Come join us on CAPS to learn more about these and countless other interesting stock ideas. Click here for a free sign-up.

Disclosure is important to us here at The Motley Fool. The stocks mentioned in this article received "five-star" ratings from participants in The Motley Fool's CAPS service and are showing strong percentage gains in today's market, at least compared with other CAPS five-star stocks. No individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated by identifying the stocks loved both by the CAPS community and by buyers in today’s market, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Ready Made Millionaire, and Motley Fool PRO services), have positions in these stocks. We thought you'd like to know that. You can learn more about The Motley Fool’s disclosure policy here.